[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 45, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 337047, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Yanez M.B.A.", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 338774, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.05, "open": 1.05, "dayLow": 1.04, "dayHigh": 1.1, "regularMarketPreviousClose": 1.05, "regularMarketOpen": 1.05, "regularMarketDayLow": 1.04, "regularMarketDayHigh": 1.1, "forwardPE": -2.1836736, "volume": 439838, "regularMarketVolume": 439838, "averageVolume": 2258735, "averageVolume10days": 550800, "averageDailyVolume10Day": 550800, "marketCap": 17404728, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 6.4, "fiftyDayAverage": 1.3968, "twoHundredDayAverage": 1.16521, "currency": "USD", "enterpriseValue": 12991766, "floatShares": 9961430, "sharesOutstanding": 16266100, "sharesShort": 440246, "sharesShortPriorMonth": 593888, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0271, "heldPercentInsiders": 0.2721, "heldPercentInstitutions": 0.05151, "shortRatio": 0.65, "shortPercentOfFloat": 0.036, "bookValue": 0.15, "priceToBook": 7.133333, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -12784287, "trailingEps": -0.86, "forwardEps": -0.49, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MIRA", "underlyingSymbol": "MIRA", "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1692019800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a71f8b50-3996-3ccd-98e2-c993481fee2f", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.07, "targetHighPrice": 17.75, "targetLowPrice": 7.5, "targetMeanPrice": 12.08, "targetMedianPrice": 11.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 2823781, "totalCashPerShare": 0.191, "quickRatio": 3.545, "currentRatio": 3.681, "returnOnAssets": -1.77528, "returnOnEquity": -7.48586, "freeCashflow": -4450804, "operatingCashflow": -4709749, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-24"}]